PMID: 9165142Apr 1, 1997Paper

Fractionated stereotactic radiotherapy for choroidal melanoma

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
K TokuuyeA Kaneko

Abstract

Stereotactic radiotherapy used for the treatment of choroidal melanoma made use of a 6-MeV linac with built-in multileaf collimators and a simple plastic head mold. The latter provided excellent head and ocular immobilization. The system resulted in highly localized dose distributions with a maximum 2-mm targeting error during fractionated treatments. Based on these techniques, sixteen patients with choroidal melanoma have so far been treated. Majority of patients received a total dose of 48 Gy in 8 fractions. Fourteen patients who presented with small- to moderate-sized tumors have remained free of relapse or major complications during the follow-up period of 3-42 months. Two patients who presented with an extensive tumor eventually required enucleation after irradiation. Technical precision required for stereotactic radiotherapy and reproducibility for fractionation appear adequate. Encouraging preliminary results justify further studies to evaluate its efficacy as an alternative to other conventional therapeutic approaches.

References

Aug 1, 1992·Ophthalmology·D R GuyerE S Gragoudas
May 1, 1992·Ophthalmology·E S GragoudasJ E Munzenrider
May 1, 1992·Ophthalmology·S PackerP T Finger
Sep 1, 1990·International Journal of Radiation Oncology, Biology, Physics·D LinstadtT L Phillips
Feb 1, 1985·International Journal of Radiation Oncology, Biology, Physics·W M SaundersS R Zink
Feb 1, 1985·Ophthalmology·E S GragoudasA Koehler
Apr 1, 1987·Ophthalmology·E S GragoudasA Koehler
Apr 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K TokuuyeS Shibui
Jul 15, 1993·International Journal of Radiation Oncology, Biology, Physics·J FontanesiD Tai

❮ Previous
Next ❯

Citations

Dec 31, 2003·International Journal of Radiation Oncology, Biology, Physics·Karin MullerPeter Levendag
Sep 20, 2005·International Journal of Radiation Oncology, Biology, Physics·Damien C WeberRaymond Miralbell
Nov 5, 2003·Ophthalmology·Ilkka PuusaariTero Kivelä
May 9, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M ZehetmayerR Pötter
Oct 2, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K DieckmannR Pötter
Jun 19, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Karin DieckmannRichard Pötter
Nov 19, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J M BuattiS L Meeks
Sep 7, 2000·International Journal of Radiation Oncology, Biology, Physics·Y C AhnS H Chang
Aug 23, 2001·International Journal of Radiation Oncology, Biology, Physics·E EggerG Goitein
Feb 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Emmanuel EggerGudrun Goitein
Apr 16, 1998·International Journal of Radiation Oncology, Biology, Physics·K TokuuyeK Nomura
Dec 30, 1998·International Journal of Radiation Oncology, Biology, Physics·K TokuuyeK Nomura
May 15, 2012·Ophthalmic Plastic and Reconstructive Surgery·Qasiem J NasserBita Esmaeli
Jul 8, 1999·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M ZehetmayerR Pötter
Feb 3, 2016·Critical Reviews in Oncology/hematology·Magali FortUNKNOWN TRONE (Transatlantic Radiation Oncology NEtwork)
Apr 5, 2013·Journal of Medical Imaging and Radiation Oncology·Claire PhillipsMathias Bressel
Jan 25, 2013·Leukemia & Lymphoma·Ryuji MikamiKoichi Tokuuye
Aug 26, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Karin MullerGré P M Luyten
Sep 7, 2000·Australasian Radiology·S SiaA Perry
Mar 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael BradaDirk De Ruysscher
Mar 8, 2003·Technology in Cancer Research & Treatment·Wolfgang A TomeJohn M Buatti
Sep 20, 2007·Technology in Cancer Research & Treatment·Raymond MiralbellLluís Escudé
May 21, 2021·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Fatih Biltekin, Gozde Yazici

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
K TokuuyeS Shibui
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Emilie T SoissonMinesh P Mehta
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
K DieckmannR Pötter
© 2021 Meta ULC. All rights reserved